43results about How to "Strong anti-infection ability" patented technology

The invention relates to a specific medicament for treating empyrosis and a preparation method thereof. The medicament comprises the following components in part by mass: 1 to 3 parts of shortleaf kyllinga herb, 1 to 3 parts of Chinese ilex leaf, 1 to 3 parts of herba pteridis multifidae, 1 to 3 parts of coriaria sinica maxim, 1 to 3 parts of hairy nanocnide, 1 to 3 parts of golden thread, 1 to 3parts of cortex phellodendri, 1 to 3 parts of baical skullcap root, 1 to 3 parts of garden burnet root, 1 to 3 parts of rhubarb, 1 to 3 parts of gypsum rubrum, 1 to 3 parts of frankincense, 1 to 3 parts of common selfheal fruit-spike and 1 to 3 parts of borneol, and the medicament also comprises sesame oil. The preparation method of the medicament comprises the following steps of: A, selecting 1 part of the high-quality shortleaf kyllinga herb, 1 part of the Chinese ilex leaf, 1 part of the herba pteridis multifidae, 1 part of the coriaria sinica maxim, 1 part of the hairy nanocnide, 1 part of the golden thread, 1 part of the cortex phellodendri, 1 part of the baical skullcap root, 1 part of the garden burnet root, 1 part of the rhubarb, 1 part of the gypsum rubrum, 1 part of the frankincense, 1 part of the common selfheal fruit-spike and 1 part of the borneol, and grinding the components into powder respectively; and B, putting the ground powder into a container, and stirring uniformly for sealing. A using method of the medicament comprises that the pasty finished medicament is applied to lesion sites for 1 to 2 hours each time, and the lesion sites are cleaned after 168 to 720 hours. The medicament, by using common Chinese medicinal herbs as raw materials, has the characteristics of quick analgesia, strong infection resistance, capability of inhibiting the exosmosis of body fluid effectively, no malformed sarcoma and cicatrices after curing, short treatment period, no toxic or side effect, low cost and the like, and can treat the empyrosis diseases completely.

The invention provides a total artificial heart device, comprising a thoracic cavity built-in part, an in-vitro drive part connected with the thoracic cavity built-in drive part and a control system with a power supply. The thoracic cavity built-in part structure simulates a human heart and is divided into four separated regions, the upper half part is a simulated atrium, and is made of hard materials, and the lower half part is composed of a soft inner container and a hard shell which form a sealing hollow cavity; the hard shell is provided with an external communication tube which is connected with a compressed package in the in-vitro drive part through a pressure regulating valve, so as to lead the sealing hollow cavity in vivo and the compressed package in the in-vitro drive part to form a communicating vessel; when the in-vitro drive part pumps liquid into the sealing hollow cavity, a pressure is applied to the soft inner container to pump out blood in the soft inner container; and when the liquid in the sealing hollow cavity is pumped out, the pressure applied on the outer side of the soft inner container is released, the inner container restores to the original condition and a negative pressure is generated so that the blood in the simulated atrium flows into a simulated ventricle. The invention has the advantages that the device has no damage on the blood and can replace the heart to work.